An enzyme-drug that prevents the essential nutrient asparagine from reaching cancer cells seem an effective way to kill them, but that enzyme-drug also does away with the nutrient glutamine that all cells need. Now a simulation has directed the mutation of the enzyme so that, in wet labs, it left normal cells unharmed in Petri dishes and cancer cells dead in test tubes. Lab tests are underway with mice. If successful, human tests are next.